Stock Taper 
BIRCHVIEW CAPITAL, LP
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Alkermes plc | ALKS | 50K | $2.62M |
 4D Molecular Therapeutics, Inc. | FDMT | 48.51K | $645.12K |
 Protagonist Therapeutics, Inc. | PTGX | 35.02K | $4.29M |
 Lam Research Corporation | LRCX | 35K | $15.17M |
 EQT Corporation | EQT | 34.62K | $1.84M |
 Halozyme Therapeutics, Inc. | HALO | 33.25K | $2.6M |
 Cytokinetics, Incorporated | CYTK | 30K | $2.56M |
 COMPASS Pathways plc | CMPS | 30K | $424.5K |
 Pharvaris N.V. | PHVS | 29.85K | $1.03M |
 Travere Therapeutics, Inc. | TVTX | 29K | $1.65M |
 Neurocrine Biosciences, Inc. | NBIX | 27.19K | $4.58M |
 Harrow Health, Inc. | HROW | 24K | $1.02M |
 Novo Nordisk A/S | NVO | 24K | $1.15M |
 Xenon Pharmaceuticals Inc. | XENE | 21.03K | $1.27M |
 Ocular Therapeutix, Inc. | OCUL | 20.66K | $202.83K |
 Trinity Capital Inc. | TRIN | 20K | $357.8K |
 Cullinan Therapeutics, Inc. | CGEM | 20K | $364.2K |
 Kayne Anderson BDC, Inc. | KBDC | 20K | $270.6K |
 Definium Therapeutics, Inc. | DFTX | 20K | $940.8K |
 Freeport-McMoRan Inc. | FCX | 18.04K | $1.13M |